483 Ascent Pharmaceuticals Sep 2013

483 Ascent Pharmaceuticals Sep 2013

Sony Mathews FDA$119.00 - Available Now

FDA investigators audited the Ascent Pharmaceuticals - Central Islip, NY, United States facility and issued inspectional observations (via FDA 483) on 26 Sep 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Sep 2013
  • Location: Central Islip, United States
  • FEI: 3009518416
Add To Cart